These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7575179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
    Gugenheim J, Baldini E, Casaccia M, Ouzan D, Saint-Paul MC, Mouiel J.
    Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L.
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP.
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
    Shimada M, Hasegawa H, Gion T, Shirabe K, Taguchi K, Takenaka K, Tanaka S, Sugimachi K.
    Hepatogastroenterology; 1999 Nov; 46(28):2469-75. PubMed ID: 10522022
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, Yoshida T.
    Hepatogastroenterology; 1999 Nov; 46(26):1083-8. PubMed ID: 10370671
    [Abstract] [Full Text] [Related]

  • 19. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
    Sonoyama T, Ochiai T, Hironaka T, Yamagishi H.
    Hepatogastroenterology; 2003 Nov; 50(52):1078-84. PubMed ID: 12845986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.